Hepatic artery infusion chemotherapy to three liver metastasis cases in which systemic chemotherapy was impossible or ineffective

Koji Ando, Eiji Oki, Yoshihiro Kakeji, Masahiko Sugiyama, Hiroshi Saeki, Kazuya Endo, Masaru Morita, Yasunori Emi, Yoshihiko Maehara

Research output: Contribution to journalArticlepeer-review

Abstract

Recently, standard therapies for either gastric cancer or colorectal cancer have been established through the development of multidrug systemic chemotherapy and the appearance of molecular targeting drugs. For example, either FOLFIRI or FOLFOX therapy is normally chosen for the treatment of unresectable liver metastasis from colorectal cancer. On the other hand, hepatic artery infusion (HAI) chemotherapy is generally used as only a second-line therapy. There are, however, some cases in which systemic chemotherapy is not indicated due to age and/or the risk of side effects. We herein report three cases that were treated by HAI after initially performing systemic chemotherapy in order to treat liver metastasis from either gastric cancer or colorectal cancer.

Original languageEnglish
Pages (from-to)2192-2194
Number of pages3
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume35
Issue number12
Publication statusPublished - Nov 2008

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Hepatic artery infusion chemotherapy to three liver metastasis cases in which systemic chemotherapy was impossible or ineffective'. Together they form a unique fingerprint.

Cite this